Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled release of proteins from degradable poly(ether-ester) multiblock copolymers.

R van Dijkhuizen-Radersma1, S Métairie, J R Roosma

  • 1OctoPlus Technologies B.V., Zernikedreef 12, 2333 CL Leiden, The Netherlands. vandijkhuizen@octoplus.nl

Journal of Controlled Release : Official Journal of the Controlled Release Society
|December 14, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis and treatment of ANCA-associated vasculitis : S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for ENT Medicine and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]

Zeitschrift fur Rheumatologie·2025
Same author

[Diagnosis and treatment of ANCA-associated vasculitis : SHORT VERSION of the S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for Otorhinolaryngology and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]

Zeitschrift fur Rheumatologie·2025
Same author

Sulfasalazine-induced mononucleosis-like-illness and haemolysis.

Scandinavian journal of rheumatology·2020
Same author

Minilaparotomy-assisted transmesenteric approach for portal vein recanalization and transjugular intrahepatic portosystemic shunt in a non-cirrhotic patient with portal cavernoma.

Diagnostic and interventional imaging·2020
Same author

[Lupus nephritis].

Der Internist·2019
Same author

Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts.

Clinical and experimental rheumatology·2015

New poly(ether-ester)s offer tunable drug delivery. Varying polymer composition controls the release of proteins like lysozyme and bovine serum albumin (BSA) via diffusion or degradation mechanisms.

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Drug Delivery Systems

Background:

  • Controlled release systems are crucial for effective drug delivery.
  • Poly(ether-ester)s offer tunable properties for biomaterial applications.
  • Understanding polymer-protein interactions is key for optimizing drug release profiles.

Purpose of the Study:

  • To develop novel multiblock poly(ether-ester)s for controlled release.
  • To investigate the release kinetics of model proteins (lysozyme and BSA).
  • To correlate protein release with polymer swelling and degradation characteristics.

Main Methods:

  • Synthesis of poly(ether-ester)s with varying poly(ethylene glycol) (PEG), butylene terephthalate (BT), and butylene succinate (BS) segments.
  • Fabrication of polymer films for protein release studies.

Related Experiment Videos

  • Evaluation of protein release profiles (lysozyme and BSA).
  • Analysis of polymer swelling and degradation behavior.

    • Main Results:

    • Lysozyme release followed first-order (diffusion-controlled) or zero-order (diffusion-degradation) profiles based on matrix composition.
    • Higher PEG content and lower BT/BS ratios increased swelling, favoring diffusion-controlled release.
    • BSA exhibited delayed release, with tunable delay time and release rate controlled by matrix swelling and degradation.

    Conclusions:

    • Poly(ether-ester) matrices provide versatile platforms for controlled protein delivery.
    • Matrix composition significantly influences swelling, degradation, and subsequent protein release kinetics.
    • Tailoring poly(ether-ester) architecture allows for precise control over drug release mechanisms and profiles.